m6A epitranscriptomics and promoter antisense RNAs in epileptogenesis: mechanisms, biomarkers, and therapeutic prospects

This publication has 76 references indexed in Scilit:

• Circadian Regulation of m6A RNA Methylation in Migraine: Mechanisms and Therapeutic Implications
  Journal of Molecular Neuroscience, 2026
• Mitochondrial dysfunction in epilepsy: mechanistic insights and clinical strategies
  Molecular Biology Reports, 2025
• The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies
  Ibrain, 2024
• Biological functions of the m6A reader YTHDF2 and its role in central nervous system disorders
  Biochemical Pharmacology, 2024
• SRF Facilitates Transcriptional Inhibition of Gem Expression by m6A Methyltransferase METTL3 to Suppress Neuronal Damage in Epilepsy
  Molecular Neurobiology, 2024
• METTL14/YTHDC1-Mediated m6A Modification in Hippocampus Improves Pentylenetetrazol-Induced Acute Seizures
  Molecular Neurobiology, 2024
• Crosstalk between m6A modification and alternative splicing during cancer progression
  Clinical and Translational Medicine, 2023
• The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model
  Synapse, 2023
• Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures
  Neurological Sciences, 2022
• N6-methyladenosine and Neurological Diseases
  Molecular Neurobiology, 2022